↓ Skip to main content

Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French…

Overview of attention for article published in Journal of Thoracic Oncology, October 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French Prospective Cohort (ERMETIC Project—Part 2)
Published in
Journal of Thoracic Oncology, October 2012
DOI 10.1097/jto.0b013e318265b2b5
Pubmed ID
Authors

Jacques Cadranel, Audrey Mauguen, Michele Faller, Gérard Zalcman, Marie-Pierre Buisine, Virginie Westeel, Elisabeth Longchampt, Marie Wislez, Bruno Coudert, Catherine Daniel, Bruno Chetaille, Stephane Michiels, Helene Blons, Jerome Solassol, Florence De Fraipont, Pascal Foucher, Thierry Urban, Ludovic Lacroix, Virginie Poulot, Elisabeth Quoix, Martine Antoine, Guillaume Danton, Franck Morin, Christos Chouaid, Jean-Pierre Pignon

Abstract

Epidermal growth factor and v-Ki-ras2 Kirsten ras sarcoma (KRAS) mutation status, although associated with EGFR- tyrosine kinase inhibitor (TKI) efficacy, has not been used in clinical practice until recently. The prospective Evaluation of the EGFR Mutation status for the administration of EGFR-TKIs in non small cell lung Carcinoma (ERMETIC) study aimed to implement these biomarkers in France.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
France 1 2%
Ireland 1 2%
Unknown 55 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 21%
Student > Ph. D. Student 10 17%
Other 8 14%
Student > Master 7 12%
Professor > Associate Professor 6 10%
Other 11 19%
Unknown 4 7%
Readers by discipline Count As %
Medicine and Dentistry 38 66%
Agricultural and Biological Sciences 3 5%
Mathematics 3 5%
Biochemistry, Genetics and Molecular Biology 2 3%
Nursing and Health Professions 2 3%
Other 5 9%
Unknown 5 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2012.
All research outputs
#3,377,964
of 4,770,046 outputs
Outputs from Journal of Thoracic Oncology
#945
of 1,700 outputs
Outputs of similar age
#52,633
of 80,436 outputs
Outputs of similar age from Journal of Thoracic Oncology
#31
of 69 outputs
Altmetric has tracked 4,770,046 research outputs across all sources so far. This one is in the 16th percentile – i.e., 16% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,700 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 80,436 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.